Latvia Pharmaceuticals & Healthcare Report Q3 2013 - New Market Research Report
While we remain of the opinion that Latvia's economy will continue to recover in 2013 and beyond, we are relatively cautious regarding the performance of its pharmaceutical market. For example, elevated unemployment will have a negative effect both on private and public (through lower tax revenues) spending on healthcare in general, particularly impacting services and treatments not covered by reimbursement. We note that private spending - of which the majority comprises out-of-pocket payments - accounts for over 40% of the...
View full press release